ProKidney Corp.
PROK • NASDAQ • Stock Fundamentals
ProKidney Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Bruce Culleton, with a market cap of $346.8M.
Market Cap$346.8M
Employees163.0
CEOBruce Culleton
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
PRO
ProKidney Corp. FAQ
Common questions about ProKidney Corp.
ProKidney Corp. (PROK) has a market capitalization of $346.8M and trades on NASDAQ.
ProKidney Corp. has approximately 163 employees.